Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
GlaxoSmithKline Product Development Pipeline
MSGene
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Episode 8 with Dr. Wendy Macklin on myelination and the zebrafish model of MS
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis.
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
Episode 31 with Dr. Lloyd Kasper on the gut microbiome and MS
The Fourth International Conference on Regulatory T Cells and TH Subsets and Clinical Applications in Human Disease
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
NYSCF Webinar Series: Multiple Sclerosis and the Promise of Stem Cell Research
The quality of reports of randomized trials in multiple sclerosis: a review.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Mechanism of action of mitoxantrone.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
XI European Meeting on Glia Cells in Health and Disease

Pages